ORTEXORTEX News
Tracking SMBK? Get live short interest, options flow, and signals on ORTEX.Sign up free →
SM
Earnings PreviewSMBK

SMBK's Sharp Options Shift Flags Defensive Tilt Into Earnings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 20 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

SmartFinancial, Inc. reports Q3 results today with one signal standing well apart from the rest: options traders have swung to their most defensive posture in months, right at the open of the earnings day.

The put/call ratio hit 5.33 on October 19, more than four standard deviations above its 20-day mean of 0.40. That z-score of 4.35 is the most extreme defensive read in months, representing a dramatic break from a period when calls dominated and the PCR rarely exceeded 0.19. Borrow conditions offer no corresponding alarm: availability is extremely loose at nearly 7,000%, with a cost to borrow of just 0.49%, so there is no squeeze dynamic in the lending market. Short interest has climbed sharply, up 28% over the past week and 61% over the past month to roughly 3.7% of the free float, which is notable for a stock of this size but still leaves the short base well below levels that would signal a structural bear thesis. FDIC data from the ORTEX Alt Data layer shows net loans and leases rising for nine consecutive quarters and total assets advancing for eight, with ORTEX's FDIC call report dataset flagging both as active streaks as of the April 2026 period. That dataset has not yet accumulated enough history to test whether it leads the company's reported figures, so it colours the picture without pointing to the print.

The analyst debate around SMBK reflects a genuinely split view on trajectory. The bull case rests on demonstrated deposit momentum, a widening net interest margin and a loan book that has compounded steadily since the Cornerstone merger. The most recent rating action, from Benchmark in August, lifted the target to $60 while maintaining a Buy, the most optimistic marker on the board. The bear case is more structural: deposit seasonality has already weighed on the loan-to-deposit ratio, and margin pressure from higher funding costs creates a narrower path for net interest income growth. Keefe, Bruyette & Woods and Stephens both hold neutral-to-equal-weight stances with targets of $50 and $47 respectively, sitting near or below the current price of $50.51. The consensus mean of $52.88 implies limited upside, and a P/E of 12.3x is modest but not obviously cheap if margin compression continues.

Institutional ownership is stable rather than contested. BlackRock held 8.6% as of September 30 and added over 183,000 shares in the latest reported period. American Century added roughly 77,000 shares in the same quarter, while Wellington trimmed by around 81,000. None of the 13D/G filings on record carry activist intent, all are passive disclosures, and no insider has made a material open-market purchase in the past 90 days. The chief credit officer sold small amounts in June and September. Among peers, SRCE and FMBH both rose around 2 to 2.5% on the week, while SMBK advanced just 0.5%, a modest lag that adds a touch of relative pressure to the setup.

The print will test whether the NIM and deposit trajectory can sustain the bull narrative at a price that has already priced in considerable progress, or whether the margin and L/D pressures the bears have flagged are materialising faster than the Street expects.

Stocks in this article

See the live data behind this article on ORTEX.

Open SMBK on ORTEX →

How this article was generated

Generated
20 Oct 2026, 04:21
Data as of
20 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.